House com­mit­tee weighs drug pric­ing pro­pos­als

The House Ways and Means Com­mit­tee on Tues­day heard tes­ti­mo­ny on ways the US could ad­dress the ris­ing cost of pre­scrip­tion drugs.

The hear­ing fol­lows two re­cent Con­gres­sion­al hear­ings on drug pric­ing held by the House Over­sight Com­mit­tee and Sen­ate Fi­nance Com­mit­tee late last month and pre­cedes a much-an­tic­i­pat­ed Sen­ate Fi­nance Com­mit­tee hear­ing on 26 Feb­ru­ary where the CEOs of drug­mak­ers Ab­b­Vie, Bris­tol-My­ers Squibb, John­son & John­son, Mer­ck, Pfiz­er and Sanofi are ex­pect­ed to tes­ti­fy.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER